4//SEC Filing
Barrage Khalil 4
Accession 0001493152-21-010465
CIK 0001022899other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 6:10 AM ET
Size
267.8 KB
Accession
0001493152-21-010465
Insider Transaction Report
Form 4
Barrage Khalil
Director
Transactions
- Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.25/sh+45,000$56,250→ 95,000 total - Exercise/Conversion
PTIX Common stock Options
2021-05-03−150,000→ 165,000 totalExercise: $1.25Exp: 2027-01-01→ PTIX common stock, Par Value $0.000001 (150,000 underlying) - Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.75/sh+45,000$78,750→ 290,000 total - Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.75/sh+120,000$210,000→ 410,000 total - Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.25/sh+150,000$187,500→ 245,000 total - Exercise/Conversion
PTIX Common stock Options
2021-05-03−45,000→ 120,000 totalExercise: $1.75Exp: 2027-10-16→ PTIX common stock, Par Value $0.000001 (45,000 underlying) - Exercise/Conversion
PTIX Common stock Options
2021-05-03−120,000→ 0 totalExercise: $1.75Exp: 2030-02-13→ PTIX common stock, Par Value $0.000001 (120,000 underlying) - Exercise/Conversion
PTIX Common stock Options
2021-05-03−45,000→ 315,000 totalExercise: $1.25Exp: 2026-04-15→ PTIX common stock, Par Value $0.000001 (45,000 underlying)
Footnotes (3)
- [F1]$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.
- [F2]Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.
- [F3]The options are fully vested.
Documents
Issuer
Protagenic Therapeutics, Inc.\new
CIK 0001022899
Entity typeother
Related Parties
1- filerCIK 0001666011
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 6:10 AM ET
- Size
- 267.8 KB